Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids

Table 4

Outcomes of symptoms in two groups.

Symptoms/group	A	B	value
Absorption of ascites	68(100%)	6(28.57%)	0.004
Recurrence rate for bleeding	7(10.29%)	2(9.52%)	0.651
Recurrence rate for ascites	11(16.18%)	3(14.29%)	0.616
HE	14(20.59%)	4(19.48%)	0.848